Newsroom

The Mitra Device is a single-use, non-sterile device used as a specimen collector and for the storage and transport of blood or other biological fluids. It is designed to be used by laboratory and healthcare professionals, or end-users as a container to collect and transport blood or other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA and/or other regulatory requirements.
The Mitra Microsampling Device is a FDA listed Class 1 exempt device, CE-IVD self-certified in the UK and EU, a Class I IVD in Australia, and registered with Health Canada. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Copyright © 2019 Neoteryx, LLC. All rights reserved.

Neoteryx Updates Its Remote Blood Collection Kits to Support Customers

Neoteryx Provides Remote Blood Collection Kits for COVID-19 Research

COVID-19 Catalyzes Remote Blood Collection With Mitra From Neoteryx

COVID-19 Screening Before Re-Entry to Work, School, Military

Neoteryx's Mitra Blood Collection Device Registered With TGA in Australia

Physicians Lab Launches Home Health & Wellness Kits With Mitra Devices from Neoteryx

Neoteryx Blood Collection Devices Support UC San Diego COVID-19 Studies

COVID-19 Tests? Consider a Finger-Prick Instead of a Regular Blood Draw

University of Rochester Examines Blood to Detect COVID-19 Antibodies

NIH Begins Study to Quantify Undetected Cases of Coronavirus Infection

GX Sciences™ now offers Microsampling, an easier and more efficient method of traditional blood sampling

Ghent University Scientists Use VAMS™ to Measure a Novel Biomarker for Alcohol Abuse

Neoteryx Expands European Footprint with Opening of Neoteryx B.V.

Neoteryx LLC Supplies Microsampling Devices for Breakthrough Home Monitoring Initiative, Making Therapeutic Drug Monitoring Fun and Easy for Pediatric Transplant Patients and Their Families

Neoteryx LLC and Cedars-Sinai Partner to Investigate At-Home Blood Sampling Possibilities for Patients with Inflammatory Bowel Disease

New Study Validates Neoteryx's VAMS™ Technology for At-home Blood Collection In Monitoring HbA1c Levels of Diabetic Children

Alcala Labs First to Integrate Neoteryx's VAMS Technology for Substance Abuse Monitoring

Duke University Uses Mitra Devices to Field-Test Diagnostic Tools in Liberia

microsampling goes mainstream

Quest Diagnostics Adds At-Home Collection to Expand Blueprint for Athletes™ Service Using Mitra Microsampling Technology

introducing the HemaTIP™, a microsampling product from Charles River Laboratories

Neoteryx announces an automation solution for Mitra Microsampling technology

Exagen Diagnostics' microsampling method gains wider acceptance

neoteryx adds 20 µL sample collection devices to Mitra microsampling portfolio

mitra microsampler now registered at FDA as a medical device

neoteryx mitra microsampling device wins R&D 100 award

neoteryx and Brechbühler partner to automate the mitra microsampling workflow

neoteryx announces european approval of the mitra microsampling device

neoteryx mitra (RUO) microsampling device simplifies collection, transport, and storage of biological fluids

phenomenex announces spin-off of a microsampling technology company – neoteryx llc

search our newsroom

news reporter resources:

social media

subscribe to news

Drop us a line

Neoteryx, LLC